Page 2 - Best Arteriovenous malformation doctors in Istanbul: TOP 22 doctors

Neurosurgery

Fields of Study and Interests

• Spina Bifida,

• Lumbar Mass,

• Tumor,

• Meningomyelocele,

• Neurological Diseases,

• Cervical Disc Hernia,

• Brain Diseases,

• Herniated disc

• Neck hernia

• Spinal Canal Stenosis

• Spondylolisthesis (Waist Slip)

• Brain Tumors

• Spinal Cord Tumors

• Spine Fracture

• Celebral hemorrhage

• Brain Aneurysm

• hydrocephalus

• Carpal Tunnel Syndrome

Education

• University of Wisconsin Neurosurgery Clinic Neurosurgery Specialization Training 2017,

Madison/USA

• Bakırköy Mental and Neurological Diseases Hospital Brain and Nerve Surgery Specialization

Training 2014, Istanbul/Turkey

• Mersin University Faculty of Medicine Medical Doctor Specialization Training 2007,

Mersin/Turkey

Career

• Istanbul Kanuni Sultan Süleyman Training and Research Hospital 2014-2021, Istanbul/Turkey

• Istanbul Bakırköy Psychiatric Hospital 2008-2014, Istanbul/Turkey

• Çorlu State Hospital 2007-2008, Çorlu/Turkey

Publications: Üçer, M. (2021). Minimally Invasive Approach Toward Percutaneous Direct Pars

Repair: An Observational Study. World Neurosurgery, 146, e1301-e1306.

Dr. Halil Can is a Professor of Neurosurgery (2025; Associate Professor 2020). He completed neurosurgical training at Istanbul University–Istanbul Faculty of Medicine in 2007. His clinical focus includes endoscopic and microsurgical spine surgery for fractures, tumors, and degenerative disease; advanced pain procedures; endoscopic skull base and pituitary surgery; and neurovascular, neuro-oncologic, and peripheral nerve surgery.

He has 21 international peer-reviewed papers (SCI/SSCI). Topics include cadaveric morphometry of Kambin’s triangle and the transforaminal triangular working zone, lumbar arterial and anterior approach anatomy, and an in vitro test of a new lumbar fixation device.

His clinical studies include a single-team series of 81 posterior circulation aneurysms, with 13 flow-diversion cases. He also reported five spinal cavernous malformation cases. He conducted Phase I safety and feasibility stem-cell trials in pediatric hypoxic-ischemic encephalopathy and in chronic complete spinal cord injury.